These funds will allow us to utilize our FALCON fatty acid motifs to advance assets into clinical development across several therapeutic areas over the next few years.

Company Information

Company Status

Private & Independent

Industry

Biopharmaceutical

Mailing Address

10655 Sorrento Valley Rd. 100
San Diego, CA 92121
USA

Phone

(732) 690-2035

Website

www.dtxpharma.com

Email Address

[email protected]

Overview

At DTx we're inspired to improve the lives of patients suffering from rare and chronic diseases worldwide by introducing next-generation, safe and effective medicines based on fatty acid motifs that deliver RNA medicines to tissues and organ systems beyond the liver.

Profile

Social Media

Company News

Facebook

YouTube

Management Team

Title

Name

Email & Social

Chief Executive Officer

Arthur Suckow

Chief Operating Officer

Denise Bevers

Chief Scientific Officer

Bryan Laffitte

Co-Founder

John Grundy

Vice President

Charles Allerson

Browse more venture capital transactions:

Prev: 3/4/2021: FutureFuel.io venture capital transaction
Next: 3/4/2021: Janux Therapeutics venture capital transaction

Share this article

About Database of VC Transactions

We do our best to record tech company VC transactions. VC investment data records on this site are sourced from news reports and company announcements. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary